Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 643

Results For "C"

9533 News Found

BDR Pharma receives Rs. 685 crore of PE investment
News | May 17, 2022

BDR Pharma receives Rs. 685 crore of PE investment

Multiples is the first private equity (PE) investor in the company


RadNet’s AI subsidiaries obtain USFDA clearance for mammography and prostrate AI tools
Drug Approval | May 17, 2022

RadNet’s AI subsidiaries obtain USFDA clearance for mammography and prostrate AI tools

Quantib Prostate is an AI-based software solution that advances the MRI prostate reporting workflow and is accessible directly from the radiologist's reading station


BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca
Biotech | May 17, 2022

BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca

A total of three targets have been selected for portfolio entry in the collaboration to date, with the potential to generate further future development milestones and sales-based royalty revenues for BenevolentAI


Sahajanand Medical Technologies win award for Supraflex Cruz
Medical Device | May 17, 2022

Sahajanand Medical Technologies win award for Supraflex Cruz

Union Minister of State for Science and Technology, Dr Jitendra Singh gave the award for the successful commercialization of indigenous technology on National Technology Day 2022


Aster DM Healthcare partners with Skye Air Mobility for drone delivery
News | May 17, 2022

Aster DM Healthcare partners with Skye Air Mobility for drone delivery

Following the successful completion of the 7day BVLOS trials, Skye Air targets to undertake approximately 80 flights, each carrying blood samples and medicines for Aster Clinics


Moderna announces advancements in mRNA platform science for application across multiple diseases
Biotech | May 17, 2022

Moderna announces advancements in mRNA platform science for application across multiple diseases

Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery


University of Nebraska Medical Center and ANANDA Scientific announce USFDA approval
Biotech | May 17, 2022

University of Nebraska Medical Center and ANANDA Scientific announce USFDA approval

The study will evaluate the effectiveness of Nantheia ATL5, an investigational drug using cannabidiol in ANANDA’s proprietary delivery technology


Boehringer Ingelheim’s treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis
Biotech | May 16, 2022

Boehringer Ingelheim’s treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis

Potential new treatment for progressive pulmonary fibrosis (PPF) builds on Boehringer Ingelheim’s leadership in lung fibrosis and will be further investigated in a phase III clinical trial program


GeneQuantum Healthcare's two bioconjugate drugs approved for clinical trials in Australia
Biotech | May 16, 2022

GeneQuantum Healthcare's two bioconjugate drugs approved for clinical trials in Australia

They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugate (AIAC) both with global intellectual property rights